Huguette Schultz

In Vitro and In Vivo Biology of Recombinant Adenovirus Vectors with E1, E1/E2A, or E1/E4 Deleted

Monika Lusky, Marielle Christ, Karola Rittner et al. · Journal of Virology · 1998 · 272 citations · Full text

Life Sciences, Genetics, Immunology +15

Tumor cell-targeting by phage-displayed peptides

Ulla Rasmussen, Valérie Schreiber, Huguette Schultz et al. · Cancer Gene Therapy · 2002 · 66 citations

Medicine, Cancer Biology, Oncology +14

In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: efficacy, toxicity and safety.

A. Bout, Imler Jl, Huguette Schultz et al. · PubMed · 1994 · 39 citations

Pharmacy, Molecular Medicine, Gene Delivery +14

<i>Trans</i> -Complementation of E1-Deleted Adenovirus: A New Vector to Reduce the Possibility of Codissemination of Wild-Type and Recombinant Adenoviruses

Jean‐Luc Imler, A. Bout, Dominique Dreyer et al. · Human Gene Therapy · 1995 · 37 citations

Pharmacy, Genetics, Molecular Biology +15

Targeting cell-specific gene expression with an adenovirus vector containing the lacZ gene under the control of the CFTR promoter.

Imler Jl, Florence Dupuit, Cécile Chartier et al. · PubMed · 1996 · 37 citations

Life Sciences, Genetics, Molecular Biology +17